๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Lifetime monoamine oxidase inhibition and sleep

โœ Scribed by Wallace B. Mendelson; Robert M. Cohen; Iain C. Campbell; Dennis L. Murphy; J. Christian Gillin; Richard Jed Wyatt


Book ID
113219217
Publisher
Elsevier Science
Year
1982
Tongue
English
Weight
230 KB
Volume
16
Category
Article
ISSN
0091-3057

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


REM sleep and central monoamine oxidase
โœ David J. Kupfer; Malcolm B. Bowers ๐Ÿ“‚ Article ๐Ÿ“… 1972 ๐Ÿ› Springer ๐ŸŒ English โš– 454 KB

Our preliminary observations on the relationship of sleep and lumbar CSF acid monoamine metabolite levels suggested a greater decrease in lumbar CSF HVA as compared to 5HIAA following clinical doses of phenelzine in the presence of virtually total REM suppression. This report on nine psychiatric pat

Anion inhibition of monoamine oxidase
โœ M.H. Van Woert; G.C. Cotzias ๐Ÿ“‚ Article ๐Ÿ“… 1966 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 640 KB
Does phentermine inhibit monoamine oxida
โœ Timothy J Maher; Ismail H Ulus; Richard J Wurtman ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› The Lancet ๐ŸŒ English โš– 80 KB
Neurotoxins and monoamine oxidase inhibi
โœ Prof. K. T. Finnegan ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 675 KB

Recent clinical studies suggest that selegiline (1.-deprenyl) is useful in retarding the progress of Parkinson's disease. an effect that may bc related to its inhibition of monoamine oxidase type B (MAO-B). Selegilinc is also reported to prevent the toxic effects of the norddrenergic neurotoxin, h~-